GlassScriptPhysician profile
Vincent J Inglima
NPI 1346745783
$3,186.83
in general payments reported to CMS, 2019-2025
23 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $1,681 · 2022: $338 · 2023: $496 · 2024: $318 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,383.93 | 2021 | |
| Smith+Nephew, INC. | $559.99 | 2019-2024 | Stravix, Grafix Pl, Coblation |
| Depuy Synthes Sales INC. | $144.21 | 2021-2023 | Quickanchor Ethibond, Truespan Orthocord |
| Anika Therapeutics, INC. | $132.20 | 2023-2024 | Tactoset, Sports Medicine |
| Treace Medical Concepts, INC. | $102.70 | 2022-2025 | |
| Orthofix Medical, INC. | $100.50 | 2025 | Truelok |
| Organogenesis INC. | $96.18 | 2023 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $95.37 | 2023 | |
| Paratek Pharmaceuticals, INC. | $89.48 | 2023-2024 | Nuzyra |
| Paragon 28, INC. | $74.84 | 2021 | |
| Globus Medical, INC. | $68.37 | 2021-2022 | |
| Abbvie INC. | $64.51 | 2022-2023 | |
| Pylant Medical | $60.01 | 2025 | |
| Polynovo North America LLC | $39.50 | 2025 | Novosorb Btm |
| Biotissue Holdings INC. | $36.45 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $24.65 | 2024 | Irrisept |
| Zimmer Biomet Holdings, INC. | $24.02 | 2021 | |
| Next Science LLC | $21.97 | 2023 | Blastx, Xperience, Surgx |
| Reprise Biomedical, INC. | $17.01 | 2022 | |
| Horizon Therapeutics Plc | $15.42 | 2023 | Krystexxa |
| Kci USA, INC. | $14.67 | 2022 | |
| Heron Therapeutics, INC. | $12.28 | 2022 | |
| Heraeus Medical, LLC. | $8.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Inglima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.